Apoptosis
Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
- Caspase(102)
- 14.3.3 Proteins(2)
- Apoptosis Inducers(45)
- Bax(7)
- Bcl-2 Family(122)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(67)
- MDM2(15)
- p53(128)
- PC-PLC(5)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(151)
- Other Apoptosis(900)
- Apoptosis Detection
- Caspase Substrate
- APC(6)
- PD-1/PD-L1 interaction(91)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(32)
Apoptosis 相关产品(2721)
- GC33401S55746 hydrochloride (BLC201 (hydrochloride))CAS: 1448525-91-4纯度: >98.50%
S55746 hydrochloride (BLC201 (hydrochloride)) (BCL201 hydrochloride) 是一种有效的,具有口服活性的选择性 BCL-2 抑制剂,Ki 为 1.3 nM,Kd 为 3.9 nM。 S55746 hydrochloride (BLC201 (hydrochloride)) (BCL201 hydrochloride) 具有低毒的抗肿瘤活性。
- GC33779Cysteamine (β-Mercaptoethylamine)CAS: 60-23-1纯度: >95.00%
2-Aminoethanethiol (cysteamine, β-Mercaptoethylamine, 2-Mercaptoethylamine, Thioethanolamine, Mercaptamine) is a radiation-protective agent that oxidizes in air to form cystamine.
- GC338154-Hydroxyphenylacetic acidCAS: 156-38-7纯度: >99.00%
A phenolic acid with anti-inflammatory and anti-steatotic activities
- GC33825Taurochenodeoxycholic acid (12-Deoxycholyltaurine)CAS: 516-35-8纯度: >98.00% / >99.00%
Taurochenodeoxycholic acid (12-Deoxycholyltaurine)是一种牛磺酸结合胆汁酸。
- GC33831Lidocaine hydrochloride (Lignocaine hydrochloride)CAS: 73-78-9纯度: >99.50% / >98.00%
Lidocaine hydrochloride (Lignocaine hydrochloride)是一种氨基酰胺类局部麻醉剂,可抑制voltage-insensitive ‘flicker’ K + channel,IC 50 值为220μM。
- GC34010Danshensu (Dan shen suan A)CAS: 76822-21-4纯度: >98.00%
丹参素是丹参的一种活性成分,通过激活 Nrf2 信号通路显示出广泛的心血管益处。
- GC34057TBHQ (tert-Butylhydroquinone)CAS: 1948-33-0纯度: >99.50%
TBHQ(tert-Butylhydroquinone)是一种强效的酚类抗氧化剂,能够减轻氧化应激和炎症反应。
- GC34092Glycochenodeoxycholic acid (Chenodeoxycholylglycine)CAS: 640-79-9纯度: >98.00%
A quantitative analytical standard guaranteed to meet MaxSpec ? identity, purity, stability, and concentration specifications
- GC34096(R)-(-)-Gossypol acetic acid (AT-101 (acetic acid))CAS: 866541-93-7纯度: >98.00%
(R)-(-)-Gossypol acetic acid (AT-101 (acetic acid))是一种新型的、具有口服活性的Bcl-2家族蛋白抑制剂,可抑制Bcl-2(K i =260±30nM),Mcl-1(K i =170±10nM)和Bcl-xL(K i =480±40nM)。
- GC34125(E)-[6]-DehydroparadolCAS: 878006-06-5
(E)-[6]-Dehydroparadol来自专利US9272994化合物M15,能够抑制人体癌细胞生长并且诱导细胞凋亡。在HCT-116和H-1299细胞中的IC50值分别为43.02和41.59μM。
- GC34134Glycocholic acidCAS: 475-31-0纯度: >98.00% / >97.00%
Glycocholic acid是一种参与脂肪乳化的结晶胆汁酸,是胆酸与甘氨酸的结合物,它以钠盐的形式存在于哺乳动物的胆汁中。
- GC34157Desacetylcinobufotalin (Deacetylcinobufotalin)CAS: 4099-30-3纯度: >99.00%
Desacetylcinbufotalin (Deacetylcinbufotalin) 是一种天然化合物;凋亡诱导剂,对HepG2细胞有明显抑制作用,IC50值为0.0279μ;mol/ml。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC33401 | S55746 hydrochloride (BLC201 (hydrochloride)) | 1448525-91-4 | >98.50% | |
S55746 hydrochloride (BLC201 (hydrochloride)) (BCL201 hydrochloride) 是一种有效的,具有口服活性的选择性 BCL-2 抑制剂,Ki 为 1.3 nM,Kd 为 3.9 nM。 S55746 hydrochloride (BLC201 (hydrochloride)) (BCL201 hydrochloride) 具有低毒的抗肿瘤活性。 | ||||
| GC33407 | BM 957 | 1391107-54-2 | - | |
BM957是Bcl-2和Bcl-xL的有效抑制剂,其Ki值分别为1.2,<1nM,IC50值分别为5.4,6.0nM。 | ||||
| GC33501 | Bornyl acetate | 76-49-3 | >99.50% / >98.00% | |
An acetate form of borneol | ||||
| GC33620 | Nec-4 | 1041644-43-2 | - | |
Nec-4,一个三环衍生物,是受体相互作用蛋白1(RIP1)的一个有效抑制剂,其IC50值为2.6μM,Ki值为0.46μM。 | ||||
| GC33699 | SAFit1 | 1643125-32-9 | >99.50% / >98.00% | |
SAFit1 是一种 FK506 结合蛋白 51(FKBP51)特异性抑制剂,其 K i 值为 4 ± 0.3nM。 | ||||
| GC33779 | Cysteamine (β-Mercaptoethylamine) | 60-23-1 | >95.00% | |
2-Aminoethanethiol (cysteamine, β-Mercaptoethylamine, 2-Mercaptoethylamine, Thioethanolamine, Mercaptamine) is a radiation-protective agent that oxidizes in air to form cystamine. | ||||
| GC33815 | 4-Hydroxyphenylacetic acid | 156-38-7 | >99.00% | |
A phenolic acid with anti-inflammatory and anti-steatotic activities | ||||
| GC33825 | Taurochenodeoxycholic acid (12-Deoxycholyltaurine) | 516-35-8 | >98.00% / >99.00% | |
Taurochenodeoxycholic acid (12-Deoxycholyltaurine)是一种牛磺酸结合胆汁酸。 | ||||
| GC33826 | C 87 | 332420-90-3 | >98.00% | |
C87是一种新型小分子TNFα抑制剂;高效抑制TNFα诱导的细胞毒性,IC50值为8.73μM。 | ||||
| GC33831 | Lidocaine hydrochloride (Lignocaine hydrochloride) | 73-78-9 | >99.50% / >98.00% | |
Lidocaine hydrochloride (Lignocaine hydrochloride)是一种氨基酰胺类局部麻醉剂,可抑制voltage-insensitive ‘flicker’ K + channel,IC 50 值为220μM。 | ||||
| GC33934 | DCVC | 13419-46-0 | >99.50% | |
DCVC (S-[(1E)-1,2-dichloroethenyl]--L-cysteine) 是三氯乙烯 (TCE) 的生物活性代谢物。 | ||||
| GC34010 | Danshensu (Dan shen suan A) | 76822-21-4 | >98.00% | |
丹参素是丹参的一种活性成分,通过激活 Nrf2 信号通路显示出广泛的心血管益处。 | ||||
| GC34021 | Vitamin K4 (acetomenaphthone) | 573-20-6 | >99.50% | |
A synthetic form of vitamin K | ||||
| GC34057 | TBHQ (tert-Butylhydroquinone) | 1948-33-0 | >99.50% | |
TBHQ(tert-Butylhydroquinone)是一种强效的酚类抗氧化剂,能够减轻氧化应激和炎症反应。 | ||||
| GC34070 | Brusatol | 14907-98-3 | >98.00% | |
Brusatol是一种Nrf2抑制剂,由从鸦嘴茅中分离提取。 | ||||
| GC34092 | Glycochenodeoxycholic acid (Chenodeoxycholylglycine) | 640-79-9 | >98.00% | |
A quantitative analytical standard guaranteed to meet MaxSpec ? identity, purity, stability, and concentration specifications | ||||
| GC34093 | SAFit2 | 1643125-33-0 | >98.50% / >98.00% | |
SAFit2是一种强效的FK506-binding protein 51 (FKBP51)抑制剂,K i 值为6nM。 | ||||
| GC34095 | ONC212 | 1807861-48-8 | >99.50% | |
ONC212是ONC201的化学类似物,是一种氟化咪唑啉酮。 | ||||
| GC34096 | (R)-(-)-Gossypol acetic acid (AT-101 (acetic acid)) | 866541-93-7 | >98.00% | |
(R)-(-)-Gossypol acetic acid (AT-101 (acetic acid))是一种新型的、具有口服活性的Bcl-2家族蛋白抑制剂,可抑制Bcl-2(K i =260±30nM),Mcl-1(K i =170±10nM)和Bcl-xL(K i =480±40nM)。 | ||||
| GC34125 | (E)-[6]-Dehydroparadol | 878006-06-5 | - | |
(E)-[6]-Dehydroparadol来自专利US9272994化合物M15,能够抑制人体癌细胞生长并且诱导细胞凋亡。在HCT-116和H-1299细胞中的IC50值分别为43.02和41.59μM。 | ||||
| GC34134 | Glycocholic acid | 475-31-0 | >98.00% / >97.00% | |
Glycocholic acid是一种参与脂肪乳化的结晶胆汁酸,是胆酸与甘氨酸的结合物,它以钠盐的形式存在于哺乳动物的胆汁中。 | ||||
| GC34157 | Desacetylcinobufotalin (Deacetylcinobufotalin) | 4099-30-3 | >99.00% | |
Desacetylcinbufotalin (Deacetylcinbufotalin) 是一种天然化合物;凋亡诱导剂,对HepG2细胞有明显抑制作用,IC50值为0.0279μ;mol/ml。 | ||||
| GC34172 | AP1867 | 195514-23-9 | >99.00% | |
AP1867是合成的FKBP12F36V的配体。 | ||||
| GC34177 | Sesamol | 533-31-3 | >99.50% | |
A lignan with diverse biological activities | ||||
